The Valley Desk

NCT04590963 · Interventional trial

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Overall registry status Active not recruiting

Phase 3

Conditions Squamous Cell Carcinoma of the Head and Neck

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov